We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$53.3M
AUM Growth
+$27.4M
Cap. Flow
-$329K
Cap. Flow %
-0.62%
Top 10 Hldgs %
81.18%
Holding
22
New
11
Increased
3
Reduced
–
Closed
3

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.09M
2
GILD icon
Gilead Sciences
GILD
+$1.32M
3
GSK icon
GSK
GSK
+$803K
4
ADMS
Adamas Pharmaceuticals
ADMS
+$575K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$4.39M
2
ATRS
Antares Pharma, Inc.
ATRS
+$723K

Sector Composition

Rank Sector Weight
1 Miscellaneous 59.73%
2 Healthcare 35.77%
3 Consumer Staples 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
CALL
Gilead Sciences
GILD
$185B
$10.1M 19.01%
+150,000
New +$9.87M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$827B
$5.86M 10.99%
+20,000
New +$5.76M
GSK icon
3
GSK
GSK
$101B
$4.8M 9.01%
96,000
+16,000
+20% +$803K
GILD icon
4
Gilead Sciences
GILD
$185B
$4.73M 8.87%
70,000
+20,000
+40% +$1.32M
ABBV icon
5
CALL
AbbVie
ABBV
$456B
$3.64M 6.82%
+50,000
New +$3.93M
JNJ icon
6
CALL
Johnson & Johnson
JNJ
$640B
$3.48M 6.53%
+25,000
New +$3.46M
LGND icon
7
PUT
Ligand Pharmaceuticals
LGND
$5.67B
$2.85M 5.35%
40,075
– –
CVS icon
8
CALL
CVS Health
CVS
$119B
$2.73M 5.11%
+50,000
New +$2.69M
TYME
9
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$2.65M 4.98%
2,175,000
– –
GNLN icon
10
Greenlane Holdings
GNLN
$1.95M
– –
0
– –
PFE icon
11
Pfizer
PFE
$160B
$2.17M 4.06%
+52,700
New +$2.09M
VKTX icon
12
Viking Therapeutics
VKTX
$3.95B
$2.08M 3.89%
250,000
– –
NVLN
13
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$1.4M 2.63%
1,800,000
– –
ADMS
14
DELISTED
Adamas Pharmaceuticals
ADMS
$1.24M 2.33%
200,000
+100,000
+100% +$575K
GWPH
15
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.03M 1.94%
+6,000
New +$1.04M
CRON
16
PUT
Cronos Group
CRON
$1.25B
$799K 1.5%
+50,000
New +$807K
ATRS
17
CALL
DELISTED
Antares Pharma, Inc.
ATRS
$658K 1.23%
+200,000
New +$579K
VIXY icon
18
CALL
ProShares VIX Short-Term Futures ETF
VIXY
$212M
$535K 1%
+313
New +$570K
TYME
19
CALL
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$122K 0.23%
+100,000
New +$140K
VKTX icon
20
CALL
Viking Therapeutics
VKTX
$3.95B
– –
-100,000
Closed -$994K
ATRS
21
DELISTED
Antares Pharma, Inc.
ATRS
– –
-250,000
Closed -$723K
AGN
22
DELISTED
Allergan plc
AGN
– –
-30,000
Closed -$4.39M

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Healthcare Value Capital held 22 positions worth $53.3M, up 105% from $26M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Healthcare Value Capital's Q2 2019 filing shows 11 new, 3 increased and 3 closed positions. Its largest new stake was Pfizer: 52,700 shares worth $2.17M. The largest sale was Allergan plc, an estimated $4.39M.

By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Healthcare Value Capital's largest Q2 2019 buy was Pfizer: 52,700 shares worth $2.17M.
  • Healthcare Value Capital added most to Gilead Sciences in Q2 2019, an estimated $1.32M increase.
  • Healthcare Value Capital fully exited Allergan plc in Q2 2019, selling an estimated $4.39M.
  • Healthcare Value Capital's ten largest holdings make up 81% of its $53.3M portfolio in Q2 2019.
  • Healthcare Value Capital opened 11 new positions and closed 3 in Q2 2019.
  • Healthcare Value Capital's portfolio value rose 105% quarter-over-quarter to $53.3M.

Based on Healthcare Value Capital's 13F filing for Q2 2019, filed 14 Aug 2019.